Can a pill prevent lung spots from turning into cancer?
NCT ID NCT04591002
First seen May 04, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This study tests whether the drug osimertinib can stop small, hazy spots (called GGNs) in the lungs from growing after surgery for a type of lung cancer. About 43 adults with stage I lung cancer and an EGFR gene mutation will take the pill daily. The goal is to see if the spots shrink or stay stable, avoiding the need for more surgery or radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SMC
RECRUITINGSeoul, Kangnamgu, 06351, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Samsung medical center
SUSPENDEDSeoul, South Korea
Conditions
Explore the condition pages connected to this study.